$73.1
+5.7
(+8.46%)▲
4.99%
Downside
Day's Volatility :7.05%
Upside
2.16%
16.79%
Downside
52 Weeks Volatility :25.29%
Upside
10.22%
Period | Centene Corp. | Sector (Health Care) | S&P500 |
---|---|---|---|
3 Months | -8.92% | 6.5% | 5.9% |
6 Months | -8.63% | 7.1% | 10.4% |
1 Year | -3.67% | 9.8% | 18.2% |
3 Years | -7.25% | 14.2% | 22.1% |
Market Capitalization | 36.0B |
Book Value | $50.26 |
Earnings Per Share (EPS) | 5.07 |
PE Ratio | 13.29 |
PEG Ratio | 0.68 |
Wall Street Target Price | 84.71 |
Profit Margin | 1.92% |
Operating Margin TTM | 4.39% |
Return On Assets TTM | 3.67% |
Return On Equity TTM | 10.44% |
Revenue TTM | 142.8B |
Revenue Per Share TTM | 264.74 |
Quarterly Revenue Growth YOY | 4.3999999999999995% |
Gross Profit TTM | 24.5B |
EBITDA | 6.1B |
Diluted Eps TTM | 5.07 |
Quarterly Earnings Growth YOY | 0.06 |
EPS Estimate Current Year | 6.83 |
EPS Estimate Next Year | 7.55 |
EPS Estimate Current Quarter | 2.08 |
EPS Estimate Next Quarter | 1.98 |
What analysts predicted
Upside of 15.88%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 60.1B | ↑ 24.25% |
Net Income | 900.0M | ↑ 8.7% |
Net Profit Margin | 1.5% | ↓ 0.21% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 74.6B | ↑ 24.16% |
Net Income | 1.3B | ↑ 46.78% |
Net Profit Margin | 1.77% | ↑ 0.27% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 111.1B | ↑ 48.87% |
Net Income | 1.8B | ↑ 36.87% |
Net Profit Margin | 1.63% | ↓ 0.14% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 126.0B | ↑ 13.38% |
Net Income | 1.3B | ↓ 25.5% |
Net Profit Margin | 1.07% | ↓ 0.56% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 144.5B | ↑ 14.74% |
Net Income | 1.2B | ↓ 10.76% |
Net Profit Margin | 0.83% | ↓ 0.24% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 154.0B | ↑ 6.54% |
Net Income | 2.7B | ↑ 124.79% |
Net Profit Margin | 1.75% | ↑ 0.92% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 35.6B | ↓ 0.85% |
Net Income | -219.0M | ↓ 129.67% |
Net Profit Margin | -0.62% | ↓ 2.68% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 38.9B | ↑ 9.36% |
Net Income | 1.1B | ↓ 615.98% |
Net Profit Margin | 2.91% | ↑ 3.53% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 37.6B | ↓ 3.29% |
Net Income | 1.1B | ↓ 6.37% |
Net Profit Margin | 2.81% | ↓ 0.1% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 38.0B | ↑ 1.15% |
Net Income | 469.0M | ↓ 55.67% |
Net Profit Margin | 1.23% | ↓ 1.58% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 39.5B | ↑ 3.73% |
Net Income | 45.0M | ↓ 90.41% |
Net Profit Margin | 0.11% | ↓ 1.12% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 40.4B | ↑ 2.4% |
Net Income | 1.2B | ↑ 2484.44% |
Net Profit Margin | 2.88% | ↑ 2.77% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 30.9B | ↑ 41.39% |
Total Liabilities | 19.9B | ↑ 32.71% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 41.0B | ↑ 32.66% |
Total Liabilities | 28.3B | ↑ 42.38% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 68.7B | ↑ 67.63% |
Total Liabilities | 42.8B | ↑ 51.07% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 78.4B | ↑ 14.05% |
Total Liabilities | 51.4B | ↑ 20.1% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 76.9B | ↓ 1.92% |
Total Liabilities | 52.6B | ↑ 2.49% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 84.6B | ↑ 10.11% |
Total Liabilities | 58.7B | ↑ 11.5% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 76.9B | ↓ 5.3% |
Total Liabilities | 52.6B | ↓ 5.29% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 83.0B | ↑ 7.95% |
Total Liabilities | 57.8B | ↑ 9.81% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 82.9B | ↓ 0.16% |
Total Liabilities | 57.1B | ↓ 1.26% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 84.4B | ↑ 1.84% |
Total Liabilities | 59.0B | ↑ 3.33% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 84.6B | ↑ 0.31% |
Total Liabilities | 58.7B | ↓ 0.47% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 82.6B | ↓ 2.38% |
Total Liabilities | 55.6B | ↓ 5.33% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.2B | ↓ 17.13% |
Investing Cash Flow | -4.6B | ↑ 262.45% |
Financing Cash Flow | 4.6B | ↓ 5724.39% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.5B | ↑ 20.18% |
Investing Cash Flow | -1.5B | ↓ 66.59% |
Financing Cash Flow | 6.8B | ↑ 48.14% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 5.5B | ↑ 271.07% |
Investing Cash Flow | -7.0B | ↑ 353.98% |
Financing Cash Flow | 260.0M | ↓ 96.19% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 4.2B | ↓ 23.59% |
Investing Cash Flow | -3.3B | ↓ 52.57% |
Financing Cash Flow | 1.4B | ↑ 423.85% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 6.3B | ↑ 48.89% |
Investing Cash Flow | -2.9B | ↓ 11.46% |
Financing Cash Flow | -4.2B | ↓ 408.15% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -1.6B | ↓ 147.3% |
Investing Cash Flow | -2.9B | ↓ 97466.67% |
Financing Cash Flow | -1.7B | ↑ 16.95% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 4.3B | ↓ 370.88% |
Investing Cash Flow | -253.0M | ↓ 91.34% |
Financing Cash Flow | -183.0M | ↓ 89.43% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 2.5B | ↓ 40.36% |
Investing Cash Flow | -424.0M | ↑ 67.59% |
Financing Cash Flow | -750.0M | ↑ 309.84% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 1.0B | ↓ 59.9% |
Investing Cash Flow | -242.0M | ↓ 42.92% |
Financing Cash Flow | -524.0M | ↓ 30.13% |
Sell
Neutral
Buy
Centene Corp. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Centene Corp. | -0.47% | -8.63% | -3.67% | -7.25% | 26.17% |
The Cigna Corp | 1.06% | 14.55% | 17.36% | 49.34% | 103.92% |
Unitedhealth Group Incorporated | 15.63% | 11.22% | 10.17% | 35.34% | 121.27% |
Cvs Health Corporation | -3.27% | -19.66% | -21.9% | -29.23% | 5.6% |
Humana Inc. | 7.01% | 6.97% | -13.79% | -17.31% | 39.56% |
Elevance Health, Inc | -3.8% | 6.25% | 9.46% | 35.81% | 71.35% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Centene Corp. | 13.29 | 13.29 | 0.68 | 6.83 | 0.1 | 0.04 | NA | 50.26 |
The Cigna Corp | 28.1 | 28.1 | 0.89 | 28.5 | 0.09 | 0.03 | 0.02 | 144.9 |
Unitedhealth Group Incorporated | 37.05 | 37.05 | 1.24 | 25.54 | 0.16 | 0.07 | 0.02 | 102.02 |
Cvs Health Corporation | 10.27 | 10.27 | 1.0 | 6.43 | 0.1 | 0.03 | 0.05 | 59.08 |
Humana Inc. | 23.82 | 23.82 | 1.64 | 16.34 | 0.12 | 0.05 | 0.01 | 133.86 |
Elevance Health, Inc | 18.22 | 18.22 | 1.14 | 37.26 | 0.17 | 0.06 | 0.01 | 181.94 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Centene Corp. | Buy | $36.0B | 26.17% | 13.29 | 1.92% |
The Cigna Corp | Buy | $97.2B | 103.92% | 28.1 | 1.77% |
Unitedhealth Group Incorporated | Buy | $515.2B | 121.27% | 37.05 | 3.66% |
Cvs Health Corporation | Buy | $73.5B | 5.6% | 10.27 | 2.04% |
Humana Inc. | Buy | $46.5B | 39.56% | 23.82 | 1.82% |
Elevance Health, Inc | Buy | $120.8B | 71.35% | 18.22 | 3.9% |
Insights on Centene Corp.
Revenue is up for the last 4 quarters, 37.60B → 40.40B (in $), with an average increase of 2.4% per quarter
Netprofit is up for the last 2 quarters, 45.0M → 1.16B (in $), with an average increase of 96.1% per quarter
In the last 1 year, The Cigna Corp has given 17.4% return, outperforming this stock by 21.1%
In the last 3 years, The Cigna Corp has given 49.3% return, outperforming this stock by 56.6%
Vanguard Group Inc
BlackRock Inc
FMR Inc
Capital World Investors
State Street Corporation
Wellington Management Company LLP
centene corporation, a fortune 500 company, is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. many receive benefits provided under medicaid, including the state children's health insurance program (chip), as well as aged, blind or disabled (abd), foster care and long term care (ltc), in addition to other state-sponsored/hybrid programs, and medicare (special needs plans). the company operates local health plans and offers a range of health insurance solutions. it also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health management, care management software, correctional healthcare services, dental benefits management, in-home health services, life and health management, managed vision, pharmacy benefits management, specialty pharmacy and telehealth services.
Organization | Centene Corp. |
Employees | 59900 |
CEO | Ms. Sarah M. London |
Industry | Health Services |
Cubesmart
$73.10
+8.46%
Iqvia Holdings Inc.
$73.10
+8.46%
Microsectors Travel 3x Inlev
$73.10
+8.46%
Jack Henry & Associates Inc.
$73.10
+8.46%
Packaging Corporation Of America
$73.10
+8.46%
Cognizant Technology Solutions Corp.
$73.10
+8.46%
Synopsys Inc.
$73.10
+8.46%
Targa Resources Corp.
$73.10
+8.46%
Parker-hannifin Corporation
$73.10
+8.46%